LIVANOVA
LIVE

Serial Number

79186202

Owner

LIVANOVA PLC

Attorney

Danielle I. Mattessich

Filing Date

Jan 27, 2016

Add to watchlist:

No watchlists yet
View on USPTO

LIVANOVA Trademark

Serial Number: 79186202 • Registration: 5061655

LIVANOVA is a trademark filed by LIVANOVA PLC on January 27, 2016. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

LIVANOVA PLC (10 trademarks)

20 Eastbourne Terrace

Entity Type: 99

Trademark Details

Filing Date

January 27, 2016

Registration Date

October 18, 2016

Published for Opposition

August 2, 2016

Goods & Services

[ Surgical apparatus and instruments for medical, dental or veterinary use; artificial limbs, eyes and teeth; orthopedic articles, namely, orthopedic hip prosthesis, orthopedic fixation device used in orthopedic transplant and/or implant surgery, orthopedic apparatus and instruments for diagnostic and therapeutic use; suture materials; medical devices involved in the field of cardiac surgery solutions, namely, aortic devices, namely, suture less valve for aortic valve replacement, mechanical heart valve prostheses, mechanical prosthesis for aortic root replacement, supra-annular aortic valve; mitral devices, namely, rigid annuloplasty rings; ] perfusion devices, namely, heart monitors and respiration monitors, and replacements parts for the monitors, perfusion systems comprised of power supply units, roller pumps and monitoring device for perfusion systems, and replacement parts for perfusion systems; cannulae for minimally invasive cardiac surgery; [ pediatric devices, namely, ] pediatric valves, pediatric hollow fiber oxygenator, pediatric arterial filters; [ medical devices involved in the field of cardiac rhythm management solutions, namely, bradyarrhythmia assessment devices, tachyarrhythmia assessment devices, heart failure assessment devices; arrhythmia assessment devices; electrophysiology electrodes and diagnostic catheters; medical devices involved in the field of neuromodulation, namely, medical system and apparatus consisting of a non-implantable modulating frequency generator, providing neuromodulation therapy to cranial and peripheral nerves, medical system and apparatus consisting of a non-implantable modulating frequency generator and implantable needle arrays for transmitting current into auricular and peri-auricular tissue for use in pain management, namely, patient stimulators for auricular and peri-auricular peripheral nerve in the field of neuromodulation therapy, implantable batteries for neuromodulation, implantable neuromodulation device that delivers a high frequency electrical signal for use in chronic pain, motor control, spasticity, and autonomic nervous system applications; medical implants including programmable pulse generators and leads used for the control of neurological disorders and neurological and muscle stimulators and related control equipment; radio frequency programming and telemetry decoders for use with medical implants; medical devices for the treatment of refractory epilepsy and treatment-resistant depression; aortic valve comprised of artificial materials for implantation; aortic clamps; mechanical heart valves comprised of artificial materials for implantation; mitral valves comprised of artificial materials for implantation; mitral rings and bands comprised of artificial materials for degenerative mitral valve regurgitation and myxomatous degeneration; minibands comprised of artificial materials for degenerative and functional mitral regurgitation and for tricuspid regurgitation; tricuspid bands comprised of artificial materials for tricuspid valve regurgitation; mitral and tricuspidal atrial blades retractors; ] medical apparatus, namely, integrated system heart lung machine disposable to optimize the extra corporeal circulation; oxygenators; patient membrane oxygenator and structural parts therefor; centrifugal blood pump system to improve outcomes for traditional bypass, mini-bypass and kinetic assist venous drainage; portable cardiopulmonary bypass systems; portable systems for extracorporeal circulation and autotransfusion; monitors for blood parameters in ECC (extracorporeal circulation); perfusion tubing systems; medical devices, namely, endoscopic vessel harvesting system and accessories sold therewith as a unit; aortic arch cannulae; venous return cannulae; suction wands and intracardiac suckers in the nature of wound suction apparatus; [ pericardiac sump pumps; ] femoral arterial (FA) and femoral venous (FV) cannulae for cannulation of femoral vessels; cannulae for pediatric cardiac surgery; [ cardiac pacemakers; defibrillators; vascular prostheses; vascular repairing parts, namely, aortic bioprosthesis heart valves, aortic pericardial heart valves, coronary bypass, implantable cardioverter-defibrillators; medical apparatus for cardiac resynchronization; accelerometer sensor as a feature of a pacemaker or defibrillator for analyzing the rhythm and range of mechanical cardiac events; medical device intended for the digital recording of multi-lead and multi-day holter data; ] all the above for medical and surgical use

[ Apparatus for recording, transmission or reproduction of sound or images; ] calculating machines, data processing equipment, computers; [ computer software for medical purposes used to analyze electrocardiographic (ECG) signals recorded with an ambulatory ECG recorder; computer software used to program heart pacemakers and defibrillators; ] software for extracorporeal circulation operation data management during cardiac surgery operations used on heart-lungs machines in the operating rooms; all the above for medical and surgical use

Filing History

INTERNATIONAL REGISTRATION RENEWED
Feb 19, 2026 RNWL
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Oct 18, 2025 REM4
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Apr 29, 2023 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Apr 29, 2023 C75A
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Apr 24, 2023 EROP
OFFICE ACTION ISSUED POU1
Oct 24, 2022 PUM1
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 24, 2022 APRE
TEAS SECTION 71 & 15 RECEIVED
Oct 17, 2022 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 18, 2021 REM3
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 4, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 4, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 4, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 4, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 4, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 4, 2021 COAR
NEW REPRESENTATIVE AT IB RECEIVED
May 31, 2019 NREP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 15, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 15, 2019 REAP
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
May 23, 2017 CORV
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 4, 2017 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 3, 2017 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Feb 14, 2017 FICS
FINAL DISPOSITION PROCESSED
Feb 13, 2017 FIMP
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2017 CRFA
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 18, 2017 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 11, 2016 OPNX
REGISTERED-PRINCIPAL REGISTER
Oct 18, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 2, 2016 NPUB
PUBLISHED FOR OPPOSITION
Aug 2, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 13, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 13, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 13, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 25, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 22, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 21, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 21, 2016 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 21, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 21, 2016 REAP
REFUSAL PROCESSED BY IB
Jun 10, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 25, 2016 RFCS
REFUSAL PROCESSED BY MPU
May 25, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 20, 2016 RFCR
NON-FINAL ACTION WRITTEN
May 19, 2016 CNRT
ASSIGNED TO EXAMINER
May 12, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 30, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 22, 2016 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 21, 2016 REPR